item management s discussion and analysis of financial condition and results of operation the following discussion of the financial condition and results of operations of the company should be read in conjunction with the company s consolidated financial statements and related notes in item of this report 
background we were incorporated in march we provide regulated medical waste collection  transportation and treatment services to our customers and related training and education programs and consulting services 
we also sell ancillary supplies and transport pharmaceuticals  photographic chemicals  lead foil and amalgam for recycling in selected geographic service areas 
we are also expanding into international markets through joint ventures or by licensing our proprietary technology and selling associated equipment 
our revenues have increased from  in to  in we derive our revenues from services to two principal types of customers i long term and sub acute care facilities  outpatient clinics  medical and dental offices  biomedical companies  municipal entities and other smaller quantity generators of regulated medical waste small account customers  and ii hospitals  blood banks  pharmaceutical manufacturers and other larger quantity generators of regulated medical waste large account customers 
substantially all of our services are provided pursuant to customer contracts specifying either scheduled or on call services  or both 
contracts with small account customers generally provide for annual price increases and have an automatic renewal provision unless the customer notifies us prior to completion of the contract 
contracts with hospitals and other large account customers  which may run for more than one year  typically include price escalator provisions  which allow for price increases generally tied to an inflation index or set at a fixed percentage 
as of december   we served over  customers 
we currently expense as incurred all permitting  design and start up costs associated with our facilities 
we elect to expense rather than to capitalize the costs of obtaining permits and approvals for each proposed facility regardless of whether we are ultimately successful in obtaining the desired permits and approvals and developing the facility 
we currently recognize as a current expense all legal fees and other costs related to obtaining and maintaining permits and approvals 
in addition  we currently expense all costs related to research and development as incurred 
year ended december  compared to year ended december  the following summarizes in thousands our operations year ended december  revenues   cost of revenues   gross profit   selling  general and administrative expenses   income from operations before acquisition related costs   acquisition related costs  income from operations   net income   depreciation and amortization   ebitda before acquisition related costs   ebitda before acquisition related costs is calculated as the sum of net income  plus net interest expense  income tax expense  depreciation expense  amortization expense  and acquisition related costs  to the extent deducted in calculating net income 
see item  note 
revenues 
our revenues increased  or  to  during the year ended december  from  during the year ended december  as we completed the acquisition of the medical waste business of browning ferris industries  inc the bfi acquisition from allied waste industries  inc  and continued to focus on sales to higher margin small account customers while simultaneously paring specified higher revenue but lower margin accounts with large account customers 
revenues generated from the sale of machinery internationally were  during as compared to  during during  acquisitions contributed approximately  to the increase in our revenues from for the year  internal growth for small account customers increased approximately while revenues from large account customers decreased by approximately 
cost of revenues 
our cost of revenues increased  or  to  during the year ended december   from  during the year ended december  the increase was primarily due to the completion of the bfi acquisition and the substantial increase in revenues during compared to and to the cost of equipment sold internationally 
our gross margin percentage increased to during from during  as a result of the further integration of new acquisitions into our existing infrastructure  lower costs relating to the changing mix of small account versus large account customers and increased utilization of treatment capacity 
selling  general and administrative expenses 
our selling  general and administrative expenses increased to  during the year ended december   from  during the year ended december  this increase was largely the result of increases in selling and marketing expenses and goodwill amortization as a result of our acquisitions  expansion of our sales network  and increased administrative expenses related to the higher volume 
selling  general and administrative expenses as a percentage of revenue decreased to during from during excluding amortization  selling  general and administrative expenses as a percentage of revenues decreased to during from during acquisition related costs 
during the fourth quarter of  we incurred integration and other non recurring acquisition costs of  related to the bfi acquisition 
these costs included severance and facility closure costs  other non recurring acquisition related costs  and transition related expenses 
we anticipate that we will incur an additional  in integration and transition related expenses during ebitda 
earnings before interest  income taxes  depreciation and amortization ebitda before acquisition related charges increased by to  or of revenues for the year ended december  as compared to  or of revenues  for the year ended december  this increase in ebitda was primarily due to the factors described above 
interest expense and interest income 
interest expense increased to  during the year ended december   from  during the year ended december   primarily due to increased borrowings for the bfi acquisition 
interest income also increased to  during from  during  primarily due to interest income on the investment of excess funds from the secondary offering of commons stock that we completed in february other income and expense 
during the year ended december   a one time gain of  on the sale of routes by ci complete compliance corporation  of which our wholly owned subsidiary  waste systems  inc is a majority shareholder  was partially offset by a one time cash expense of  for warrants issued with bridge loan borrowings in december and january income tax expense 
income tax expense for the year ended december  reflects a one time tax benefit of  recorded in compliance with fasb under fasb  we are required to recognize our net deferred assets if we believe that we are more likely than not to benefit from our carryforward losses and tax credits in future years 
year ended december  compared to year ended december  the following summarizes in thousands our operations year ended december  revenues   cost of revenues   gross profit   selling  general and administrative expenses   income from operations   net income   depreciation and amortization   ebitda   ebitda is calculated as the sum of net income  plus net interest expense  income tax expense  depreciation expense  and amortization expense to the extent deducted in calculating net income 
see item  note 
revenues 
our revenues increased  or  to  during the year ended december  from  during the year ended december  as we continued to focus on sales to higher margin small account customers while simultaneously paring certain lower margin large account customers 
the increase also reflects  in revenues from the sale of equipment to a brazilian company  companhia auxiliar de viacao e obras cavo  and to a mexican joint venture  medam sa de sa medam  that we and others formed for the collection  treatment and disposal of regulated medical waste in the mexico city metropolitan market utilizing the our etd treatment technology 
during  acquisitions contributed approximately  to the increase in our revenues from for  internal growth from small account customers increased while revenues from large account customers decreased by 
cost of revenues 
our cost of revenues increased  or  to  during the year ended december   from  during the year ended december  the increase was primarily due to the substantial increase in revenues during compared to and to the cost of equipment supplied to cavo and medam 
our gross margin percentage increased to during from during as a result of the sale of equipment internationally  further integration of new acquisitions into our existing infrastructure  lower costs relating to the changing mix of small account and large account customers and increased utilization of existing treatment capacity 
selling  general and administrative expenses 
our selling  general and administrative expenses increased to  during the year ended december   from  during the year ended december  due to our continued progress in strengthening our sales and administrative organizations and to the increase in the amortization of goodwill associated with acquisitions 
selling  general and administrative expenses as a percentage of revenues decreased to during from during excluding amortization  selling  general and administrative expenses as a percentage of revenue decreased to during from during ebitda 
ebitda increased by to  or of revenues  for the year ended december  as compared to  or of revenues  for the year ended december  this increase in ebitda was primarily due to the factors described above 
interest expense and interest income 
interest expense increased to  during the year ended december   from  during the year ended december   primarily due to borrowings on our revolving line of credit offset by the repayment of certain debt issued in connection with one of our acquisitions 
interest income also increased to  during from  during  primarily due to interest income on the subordinated debt of med tech environmental ltd 
that acquired in october  offset by lower cash balances 
income tax expense 
the estimated effective tax rate of approximately for the year ended december  reflects the utilization of our net operating losses for income tax purposes offset by alternative minimum tax and state income taxes in states where we have no offsetting net operating losses 
liquidity and capital resources at december   our working capital was  compared to working capital of  at december  the increase in working capital was primarily due to higher cash and accounts receivable balances as a result of the bfi acquisition 
net cash provided by operating activities was  during the year ended december  compared to  for the year ended december  this increase primarily reflects higher net income and depreciation and amortization expense  offset by changes in working capital 
net cash used in investing activities for the year ended december  was  compared to  for the year ended december  this change is primarily attributable to the increase in cash used for funding acquisitions and international investments completed in capital expenditures were  for compared to  for payments for acquisitions and international investments amounted to  during primarily related to the bfi acquisition which we completed in november in order to finance the bfi acquisition  we conducted a series of financings 
as a result  we are a substantially leveraged company 
we also recorded a substantial increase in goodwill and other intangible assets in connection with the bfi acquisition  and we will experience a corresponding large increase in our amortization expense 
we have a credit agreement with a group of lenders that provides for an aggregate of up to million in senior secured financing comprised of i a six year term loan a amortizing facility of million  ii a seven year term loan b amortizing facility of million  and iii a million revolving loan facility 
as of december  we had not drawn on the revolving loan facility 
in addition  we issued series a senior subordinated notes due in the aggregate principal amount of million to donaldson  lufkin jenrette securities corporation  bear  stearns co  inc credit suisse first boston corporation and warburg dillon read llc 
pursuant to a series a convertible preferred stock purchase agreement  on november  we issued and sold to investment funds associated with bain capital  inc and madison dearborn partners llc  a total of  shares of our convertible preferred stock for  per share  or an aggregate of million  in cash  less fees of million 
dividends on the convertible preferred stock are payable in kind in additional shares and accrue at the annual rate of  subject to adjustment 
net cash provided by financing activities was  during the year ended december  compared to  for the year ended december  the difference between the two years results primarily from the completion of the financings previously described and of our second public offering of common stock in february  in which raised  net of offering costs 
our other financial obligations include industrial development revenue bonds issued on behalf of and guaranteed by us to finance our woonsocket  rhode island treatment facility and equipment 
these bonds  which had an outstanding aggregate balance of  as of december  at fixed interest rates ranging from to  are due in various amounts through june in addition  we have issued various promissory notes in connection with acquisitions during and  consisting primarily of a year note issued as a part of the environmental control corporation  inc acquisition  which has an outstanding balance of  at december  recently issued accounting standards in june  the financial accounting standards board issued sfas no 
 accounting for derivative instruments and hedging activity 
sfas no 
provides comprehensive and consistent standards for the recognition and measurement of derivative and hedging activities 
it requires that derivatives be recorded on our consolidated balance sheet at fair value and establishes criteria for hedges of changes in fair value of assets  liabilities or firm commitments  hedges of variable cash flows of forecasted transactions and hedges of foreign currency exposures of net investments in foreign operations 
changes in the fair value of derivatives that do not meet the criteria for hedges would be recognized in our consolidated statement of earnings 
this statement will be effective for us beginning january  the adoption of sfas no 
is not expected to have a material impact on us 
item a 
quantitative and qualitative disclosures about market risk our exposure to market risk includes the possibility of rising interest rates in connection with our senior credit facility  thereby increasing our debt service obligations  which could adverse affect our cash flows 
see item  management s discussion and analysis of financial condition and results of operation liquidity and capital resources 

